Posttranscriptional processing of RNA produces an exceptional number and structural diversity of modified nucleosides, properties long recognized as characteristic features of RNA (1, 2) . In parallel with steadily increasing knowledge of the array of functional roles of modification (3, 4) , and indeed of the multiple roles of RNA itself (5) , the continuing discovery of new nucleosides mandates a need for a comprehensive listing of RNA nucleosides, and a means for access to the substantial body of relevant literature. The present compilation consists of all reported modified ribonucleosides of known structure, including those from established sequence positions as well as those derived from enzymatic or chemical hydrolysates of RNA. Included are nucleosides from mutant organisms as well as compounds considered to be undermodified (a somewhat ambiguous term) as a result of metabolic or physiological stress. Excluded are those known to be artifactual, for example as a consequence of degradation, or those having clearly incorrect structures. If the basis of structure assignment or identification is considered to be inconclusive, this is indicated under the Notes column.
There are two notable examples of modification that have not been included in the compilation. The covalently bonded adduct between the tRNA nucleoside A^-threonylcarbamoyladenosine (structure 11) and the base Tris, is a complex nucleoside isolated and characterized from E.coli tRNA (6) (Chemical Abstracts registry number 61172- , and is presently believed to be formed in vitro during tRNA isolation (6) , and is thus not a fully natural nucleoside. Second, posttranscriptional methylation in some small nuclear RNAs results in a 5'-CH 3 pppN... structure, rather than the more common m 2 ' 2>7 GpppN... cap in which the terminus is a nucleoside (7) .
Entries are categorized primarily by type of RNA, although in early work total cellular RNA was often isolated with no clear distinction made between tRNA ('soluble RNA'), the various rRNAs ('microsomal') or others. In such cases the listing given may correspond to contemporary knowledge of distribution of the nucleoside within certain types of RNA. Some of the earlier literature concerning modification in rRNA is of questionable accuracy, and this particular problem is addressed in a later section. Many entries in the list were acquired by systematic examination of certain parts of the earlier literature, as well as through computer-based literature searches using Chemical Abstracts registry numbers for the nucleoside or (less commonly) the base. Registry numbers for both the nucleoside, and base (if assigned), are provided in the present listing. Their use is recommended for effective access to the modified nucleoside literature, including such topics as chemical synthesis (which for some compounds is extensive), biosynthesis, modification enzymes, function, and occurrence in specific biological sources.
Earlier listings and reviews of modification in RNA, including sequence placement in some cases, include the following: chemical synthesis (8) , general distribution (9) , tRNA distribution (10) and sequences (11) , mitochondrial tRNA (12) , archaeal tRNA (13) , eukaryotic rRNA (14) , mRNA cap structures (15, 16) and small nuclear RNA (17, 18) .
DESCRIPTION OF ENTRIES Structure number
Structures of the ribonucleosides are given on accompanying pages, even though in a minority of cases the structure assignment or principal literature may deal with the corresponding base. Side chain stereochemical assignments are not shown but are indicated in some cases in the Chemical Abstracts Index Name.
Common name
The most commonly used or preferred name is listed. For some nucleosides, additional alternate names are in common use, for example, 5-methyluridine in lieu of ribosylthymine (structure 52), or 'Q nucleoside' instead of queuosine (structure 43).
Symbol
The symbols listed follow convention and usage in the literature, even though some of the notations are idiosyncratic. In general, terms preceding the principal symbol (A, C, G, U) designate modification in the base, while methylation or ribosylation at 0-2' of ribose (the only known ribose modifications in RNA) are designated by 'm' or 'r', respectively, following the principal symbol. Numerous symbols, many of them inconsistent, have been used for the ' Y' family of nucleosides and bases (structures 37-42). The recommended symbols for those nucleosides are shown in the table; further comments are made in the Notes entries, including recommended symbols for the corresponding bases.
In general, the symbol 'N' is preferred for modified nucleosides of unknown structure, or 'Nm' if ribose methylation of O-2' has been established. If the heterocyclic moiety is known or assumed, for example from the corresponding gene sequence, the designation A*, U*, etc. is recommended. The use of 'X' for an unknown nucleoside is not recommended because of confusion with the nucleoside acp 3 U (see Note 34) . The superscript 'x' is useful to indicate a form of modification without designation of position; for example 'm x C for cytidine monomethylated in the base at an unknown or unspecified position. Likewise 'x' is sometimes used in the fashion 'x 5 s 2 U', as to generically designate 5-substituted derivatives of 2-thiouridine. The use of 'm' for 'modified', as in 'mA' (occasionally used in the rRNA literature) is strongly discouraged because of the ambiguity associated with use of 'm' for methylation.
Chemical Abstracts registry number
Registry numbers are listed for the ribonucleoside and base (if assigned). The registry numbers may be used in combination with other search terms to allow selective computer-based literature retrievals. For instance, use of registry number 24719-82-2 (for t^A) in combination with 'synthesis' produces eight citations dealing with the chemical synthesis of ^A.
Chemical Abstracts index name
The name given is that assigned to the ribonucleoside. It is noted that in a limited number of cases, stereochemical assignment in the name was (correctly) made based on an early literature report, but was then automatically assigned without verification in all subsequent reports. For example the amino acid moiety for structure 77 is designated by index name and registry number as L-threonine, with the implication that all later reports of t 6 A in tRNA deal specifically with the L-enantiomer of threonine.
Source
For each entry the known occurrence for each nucleoside within the type of RNA is listed as: A, archaea (archaebacteria); B, bacteria (eubacteria); E, eukarya (eukaryotes). Although organelle rRNAs have not been cataloged, mt (mitochondrial) is used when initial characterization was from this source. V (viral) designations are used in the mRNA section. For tRNA, specific literature citations are not given for occurrence in each of the three basic phylogenetic domains because much of this information was earlier cataloged and is readily available. The tRNA source distributions indicated have been determined from the sequence databank (9), the Structure column citations, or from specific citations retrieved using registry numbers. For all other RNA classes, citations are given to the first reported identification of the nucleoside in the source indicated. For example, the occurrence of A^-methylguanosine (structure 30) was reported in snRNA in 1972 (ref. 193) 
Structure
The citation given is usually to the first report of structure assignment for the nucleoside, regardless of RNA source. Two primary citations are listed if the second one further refines the structure (e.g., side chain stereochemistry) or addresses ambiguities in the first report. Citations to incorrect structures, as opposed to incomplete ones, are not listed. Reference to structural characterization of the base rather than the nucleoside has been given in the case of some early studies in which chemical hydrolysis to the base was often employed prior to identification, and for some of the Y nucleosides which were isolated as bases (structures 37-42) as a consequence of the unusual acid lability of the glycosidic bond.
Synthesis
In each case the citation listed is to the first reported chemical synthesis of the ribonucleoside, or in limited cases, of the base. The chemical synthesis literature for many nucleosides is extensive, and no attempt has been made to cite additional syntheses even though they often represent improvements over the first reported synthesis. Access to the synthesis literature can be made effectively through Chemical Abstracts registry numbers. In general, many physical and spectroscopic data of interest (UV and mass spectra, chromatographic properties) are available from the first synthesis and structure characterization citations listed. The absence of a citation indicates the finding that no chemical synthesis has been reported.
Notes
Additional literature citations, alternate nomenclature, or further comments on entries in the preceding columns are provided.
NUCLEOSIDE MODIFICATION IN RIBOSOMAL RNA
Posttranscriptional modification in rRNA was recognized and reported in the early literature, but has received far less attention than for tRNA because of limited sequence studies carried out at the RNA level (which was a historically a frequent means of discovery of new nucleosides in tRNA), coupled with considerably less understanding of modification structurefunction relationships compared with tRNA. In compiling a comprehensive and reliable listing of modified nucleosides in rRNA, several problems arose that were common to all of the RNAs but were perhaps more prevalent for rRNAs. First, some early work predated an understanding of the structures of rRNAs and of methods to isolate them without cross-contamination from other rRNAs, or from tRNA. Second, methods of structural identification prior to about 1965 were inadequate in the event that structurally new or unexpected nucleosides were encountered, and some identifications based principally on chromatographic behavior must be regarded as inconclusive even though no outright assignment error is apparent. In addition, RNA hydrolysis using acid or base (rather than nucleases) must have inevitably led to some formation of degraded or rearranged products, and loss of labile substituents, which were not readily recognized as such. As a consequence of these problems, some of the assignments listed in the rRNA section of the database are tenuous (as indicated under Notes) and should be verified using rigorous experimental methods.
Because of the relatively greater extent to which modifications in E.coli rRNA have been studied, it is possible to compare earlier reports with more recent work (19) , and thereby exclude onetime or unusual assigments that have not been subsequently verified by independent methods. On this basis, the following reported nucleoside occurrences in E.coli rRNA have not been listed in the table: mjG (20) , and D (21) (22) in 23S. In spite of the problems outlined above, and because of the absence of any previous attempt to compile a comprehensive listing of rRNA modifications, the view has been adopted that the rRNA list should be published at this time, even though uncertainties remain.
SUMMARY
A total of 93 modified nucleosides for which structures have been assigned have been reported in RNA. The largest number, 79, with the greatest structural diversity, are found in tRNA, with 28 in rRNA, 12 in mRNA and 12 in other RNA species, most notably snRNA. Based on lessons learned primarily from tRNA, it is clear that many modification motifs and their sequence locations tend to be conserved, although distinct differences among the three primary phylogenetic domains are observed. The fewer number of modifications reported from the archaeal RNAs, to a limited extent, reflects fewer investigations compared with bacteria and eukarya. In any event, it is clear that present knowledge of the structural diversity of RNA nucleosides, and certainly of their distribution, is somewhat narrowly confined to relatively few organisms. It is the authors' judgement that the total number of RNA nucleosides listed, and the chemical structures reported, are very accurate. However, the distributions listed are in some cases a matter of concern, due primarily to the possibility of RNA inhomogeneity and the use of methods of nucleoside identification that are not sufficiently rigorous. Reinvestigation of some of the unusual or single-report source distributions is warranted, and will likely lead to future refinements in the listings.
It is the authors' intention to maintain this compilation as a continuously updated database. Comments concerning format, omissions or newly published material are solicited. 
Chemical Abstracts Registry Number Chemical Abstracts'Index Name 
IH-Purinium, 2-amino-6,9-dihydroxy-7- (18) . 7 Also known as cts-zeatin riboside (symbol cZ). The name zeatin riboside refers to the rra/is-isomer, a cytokinin (registry number 6025-53-2). 2 U, has been structurally characterized, it is likely that others exist but have not been detected due to oxidation, for example, in eukaryotic tRNA (127) . 43 The first preparation of ncm 5 Um was by conversion of cm'Um which had been isolated from tRNA in the same study (117 (structure 87) were identified as the monophosphates by their UV spectra following separation by 2D-TLC (data not shown) (160); however, availability of authentic compounds or of previously cited properties was not addressed. These structure assignments are therefore considered inconclusive. 52 Although this nucleoside was reported in both 18S and 28S rRNA from HeLa cells (137) , later studies showed it to be confined to the I8S rRNA (139). 53 Verification that the early report of m 3 U synthesis (172) was correct was made much later (173) . Although this nucleoside was reported present in both 18S and 28S rRNA from HeLa cells (137) , later studies showed it to be confined to the 28S rRNA (138) . In a recent examination of E.coli 23S rRNA, m 58 This 5'-cap nucleoside is joined to the RNA through a unique 3'-triphosphate bridge (GpppN...). 59 The structure was first assigned using material from 2-10S RNA from Chinese hamster ovary cells (192) , and later from snRNA from Novikoff hepatoma ascites cells (193) . More rigorous characterization of the synthetic nucleoside used for comparison is given in ref. 194 . This nucleoside is rare in mRNA. 60 Am, *, and the m 2 ' 2>7 G cap nucleoside are also found in U3 RNA from the nucleolus. See Note 66. 61 Dihydrouridine is reported in a total enzymatic digest of nuclear 5S RNA from rat (196) . However, this sole report of D in snRNA was not verified by sequencing of the RNA because pD could not be distinguished from pU (196 
